BridgeMD
New treatment option for EEG Brain Oscillations
Official title Effects of Endogenous Gamma Light Stimulation on Brain Oscillations in Cognitively-normal Older Adults
ClinicalTrials.gov ID: NCT06715995
What this study is testing
- What it's testing
- This study aims to evaluate the effects of endogenous gamma non-flickering light stimulation on resting-state EEG rhythms and cognitive function in cognitively healthy older adults. Specifically, it will assess the immediate and long-term effects of this stimulation on brainwave activity and cognitive performance.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 55 and older. Healthy volunteers may be eligible.
You may be able to join if
- 1\. Age over 55 years old.
- 2\. The Cognitive Abilities Screening Instrument (CASI) score is within normal ranges adjusted for age and education.
- 3\. Participants have no history of severe neurological or psychiatric disorders (such as stroke, epilepsy, depression, migraine, etc.) that could...
- 4\. Participants have not used drugs that may affect cognitive function (e.g., benzodiazepines, anticholinergic medications, etc.).
- 5\. Participants with normal or corrected vision (e.g., glasses or contact lenses) to normal levels.
You likely can't join if
- 1\. Participants enrolled in any cognitive enhancement study within the past two months.
- 2\. Participants with a history of disease that could affect cognitive function (e.g., cancer, autoimmune diseases, etc.).
- 3\. Pregnant, or planning to become pregnant.
See the full eligibility criteria
- 1\. Age over 55 years old.
- 2\. The Cognitive Abilities Screening Instrument (CASI) score is within normal ranges adjusted for age and education.
- 3\. Participants have no history of severe neurological or psychiatric disorders (such as stroke, epilepsy, depression, migraine, etc.) that could affect cognitive function.
- 4\. Participants have not used drugs that may affect cognitive function (e.g., benzodiazepines, anticholinergic medications, etc.).
- 5\. Participants with normal or corrected vision (e.g., glasses or contact lenses) to normal levels.
- 6\. Voluntary to sign the Informed Consent Form.
- 1\. Participants enrolled in any cognitive enhancement study within the past two months.
- 2\. Participants with a history of disease that could affect cognitive function (e.g., cancer, autoimmune diseases, etc.).
- 3\. Pregnant, or planning to become pregnant.
The study team makes the final eligibility decision.
Where it's taking place
- Taoyuan, Guishan, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 55 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taoyuan, Guishan, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.